PKCθ promotes c-Rel-driven mammary tumorigenesis in mice and humans by repressing estrogen receptor α synthesis

被引:62
作者
Belguise, Karine
Sonenshein, Gail E.
机构
[1] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Womens Hlth Interdisciplinary Res Ctr, Boston, MA 02118 USA
关键词
D O I
10.1172/JCI32424
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The vast majority of primary human breast cancer tissues display aberrant nuclear NF-kappa B c-Rel expression. A causal role for c-Rel in mammary tumorigenesis has been demonstrated using a c-Rel transgenic mouse model; however, tumors developed with a long latency, suggesting a second event is needed to trigger tumorigenesis. Here we show that c-Rel activity in the mammary gland is repressed by estrogen receptor alpha (ER alpha) signaling, and we identify an epigenetic mechanism in breast cancer mediated by activation of what we believe is a novel PKC theta-Akt pathway that leads to downregulation of ER alpha synthesis and derepression of c-Rel. ER alpha levels were lower in c-Rel-induced mammary tumors compared with normal mammary gland tissue. PKC theta induced c-Rel activity and target gene expression and promoted growth of c-Rel- and c-ReNCK2 alpha-driven mouse mammary tumor-derived cell lines. RNA expression levels of PKC theta and c-Rel target genes were inversely correlated with ERa levels in human breast cancer specimens. PKC theta activated Akt, thereby inactivating forkhead box O protein 3a (FOXO3a) and leading to decreased synthesis of its target genes, ERa and p27(KiP1). Thus we have shown that activation of PKC theta inhibits the FOXO3a/ER alpha/p27(Kip1) axis that normally maintains an epithelial cell phenotype and induces c-Rel target genes, thereby promoting proliferation, survival, and more invasive breast cancer.
引用
收藏
页码:4009 / 4021
页数:13
相关论文
共 62 条
[1]  
BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842
[2]   Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor α expression reversing invasive phenotype of breast cancer cells [J].
Belguise, Karine ;
Guo, Shangqin ;
Sonenshein, Gail E. .
CANCER RESEARCH, 2007, 67 (12) :5763-5770
[3]  
BIRT DF, 1995, J NUTR, V125, pS1673
[4]   IMMUNOLOGICAL QUANTITATION OF PHOSPHOLIPID/CA-2+-DEPENDENT PROTEIN-KINASE OF HUMAN MAMMARY-CARCINOMA CELLS - INVERSE RELATIONSHIP TO ESTROGEN-RECEPTORS [J].
BORNER, C ;
WYSS, R ;
REGAZZI, R ;
EPPENBERGER, U ;
FABBRO, D .
INTERNATIONAL JOURNAL OF CANCER, 1987, 40 (03) :344-348
[5]   Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a) [J].
Brunet, A ;
Park, J ;
Tran, H ;
Hu, LS ;
Hemmings, BA ;
Greenberg, ME .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (03) :952-965
[6]   Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor [J].
Brunet, A ;
Bonni, A ;
Zigmond, MJ ;
Lin, MZ ;
Juo, P ;
Hu, LS ;
Anderson, MJ ;
Arden, KC ;
Blenis, J ;
Greenberg, ME .
CELL, 1999, 96 (06) :857-868
[7]   Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor α -: A new model for anti-estrogen resistance [J].
Campbell, RA ;
Bhat-Nakshatri, P ;
Patel, NM ;
Constantinidou, D ;
Ali, S ;
Nakshatri, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (13) :9817-9824
[8]   Selective inhibition of protein kinase C isozymes by Fas ligation [J].
Chen, CY ;
Faller, DV .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (22) :15320-15328
[9]   Genomic and transcriptional aberrations linked to breast cancer pathophysiologies [J].
Chin, Koei ;
DeVries, Sandy ;
Fridlyand, Jane ;
Spellman, Paul T. ;
Roydasgupta, Ritu ;
Kuo, Wen-Lin ;
Lapuk, Anna ;
Neve, Richard M. ;
Qian, Zuwei ;
Ryder, Tom ;
Chen, Fanqing ;
Feiler, Heidi ;
Tokuyasu, Taku ;
Kingsley, Chris ;
Dairkee, Shanaz ;
Meng, Zhenhang ;
Chew, Karen ;
Pinkel, Daniel ;
Jain, Ajay ;
Ljung, Britt Marie ;
Esserman, Laura ;
Albertson, Donna G. ;
Waldman, Frederic M. ;
Gray, Joe W. .
CANCER CELL, 2006, 10 (06) :529-541
[10]   Insulin-like growth factors control the regulation of oestrogen and progesterone receptor expression by oestrogens [J].
Clayton, SJ ;
May, FEB ;
Westley, BR .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1997, 128 (1-2) :57-68